This grant supports mid-phase clinical trials of promising natural products for determining optimal doses/formulations or patient responses, excluding cancer trials.
National Institutes of Health has archived this opportunity.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
Supporting feasibility trials of mind and body interventions for high-priority health conditions to inform future clinical trials for enhanced public health impact.
Funding for clinical trials testing complementary health interventions remotely, emphasizing safety and feasibility with mHealth tools, requiring a diverse perspective plan.
This grant funds early stage trials of new drugs and neuromodulatory devices for psychiatric disorders, aiming to de-risk and attract further funding.
NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.